Representing a significant advancement in healthcare, endovascular procedures performed inside blood vessels embody the intersection of medicine and technology. By addressing critical conditions such ...

Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY ® Endovascular Robotic System, announced that Harel Gadot, CEO, President and Chairman, will be a featured ...

Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.

BRAINTREE, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT) today announced it has entered into an agreement with Emory University, which will allow the parties to evaluate and ...

HINGHAM, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (MBOT), developer of the innovative LIBERTY ® Endovascular Robotic System, announced its participation in the inaugural ...

LIBERTY® Continues to Gain Commercial Traction and Exposure as Part of Its Limited Market Release (LMR) in the US ...

Detailed price information for Microbot Medical Inc (MBOT-Q) from The Globe and Mail including charting and trades.

Microbot Medical Inc. MBOT recently announced that it has entered into an agreement with Emory University, which is likely to allow the entities to evaluate and explore the potential for future ...

HINGHAM, Mass., April 09, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic System, presented for the first time the data from ...

Microbot Medical, a surgical robotics company, has announced the FDA approval to start its human clinical trials for the Liberty Endovascular Robotic Surgical System. The Liberty system was designed, ...

Microbot Medical has secured FDA clearance for the LIBERTY System, the first FDA-approved, single-use, remotely operated robotic system for peripheral endovascular procedures. With the clearance ...